Citicoline: Clinical Trials

5 trials of Citicoline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 withdrawn. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 4, Withdrawn 1

Follow Citicoline: new trials by email Literature Review of Citicoline trials Research Report on Citicoline

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ramelteon and Citicoline for Delirium
Ramelteon, Citicoline - Delirium
Phase 4WithdrawnUniversity of Texas Southwestern Medical Center2016-07-012017-11-09
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders
Placebo, Citicoline, Pregnenolone - Alcohol Use Disorder, Bipolar Disorder
Phase 4CompletedSherwood Brown, MD, PhD962016-05-012024-10-09
Citicoline for Alcohol Dependence
Placebo, Citicoline - Alcohol Dependence
Phase 4CompletedUniversity of Texas Southwestern Medical Center622014-04-012018-07-24
Citicoline for Bipolar 1 Disorder and Cocaine Dependence
Citicoline, Placebo, Cognitive Behavioral Therapy (CBT) - Bipolar Disorder, Cocaine Dependence
Phase 4CompletedUniversity of Texas Southwestern Medical Center1302008-04-012018-01-24
Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases
Citicoline - Glaucoma, Optic Neuropathy, Ischemic
Phase 4CompletedFondazione G.B. Bietti, IRCCS602005-02-282021-02-03

Conditions studied

Alcoholism (2)  ·  Bipolar Disorder (2)  ·  Cocaine-Related Disorders (1)  ·  Delirium (1)  ·  Glaucoma (1)  ·  Optic Neuropathy, Ischemic (1)

Sponsors

University of Texas Southwestern Medical Center (3)  ·  Fondazione G.B. Bietti, IRCCS (1)  ·  Sherwood Brown, MD, PhD (1)

Countries

United States (4)  ·  Italy (1)

Top investigators

E. Sherwood Brown, MD, PhD (1)  ·  Sherwood Brown, M.D., Ph.D. (1)  ·  Sherwood Brown, MD, PhD (1)  ·  Vincenzo Parisi, MD (1)

Results publications

PMID 16249960, PMID 25998279

NIH funding

R01DA022460 (1)